Cramer Pamela J. bought RYTM

November 7, 2025 · Form 4 insider transaction

Cramer Pamela J. bought 8,805 shares of Rhythm Pharmaceuticals, Inc. at $19.02 per share, a transaction worth $167.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.